BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31097513)

  • 1. Staging early cervical cancer in China: data from a multicenter collaborative.
    Zhang W; Chen C; Liu P; Li W; Hao M; Zhao W; Lu A; Ni Y
    Int J Gynecol Cancer; 2019 May; ():. PubMed ID: 31097513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re-classification of uterine cervical cancer cases treated with radical hysterectomy based on the 2018 FIGO staging system.
    Osaku D; Komatsu H; Okawa M; Iida Y; Sato S; Oishi T; Harada T
    Taiwan J Obstet Gynecol; 2021 Nov; 60(6):1054-1058. PubMed ID: 34794737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locoregional spread and survival of stage IIA1 versus stage IIA2 cervical cancer.
    Hongladaromp W; Tantipalakorn C; Charoenkwan K; Srisomboon J
    Asian Pac J Cancer Prev; 2014; 15(2):887-90. PubMed ID: 24568513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological risk factors in the light of the revised 2018 International Federation of Gynecology and Obstetrics staging system for early cervical cancer with staging IB: A single center retrospective study.
    Zeng J; Qu P; Hu Y; Sun P; Qi J; Zhao G; Gao Y
    Medicine (Baltimore); 2020 Apr; 99(16):e19714. PubMed ID: 32311956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fertility sparing therapy in women with lymph node negative cervical cancer >2cm - oncologic and fertility outcomes of neoadjuvant chemotherapy followed by radical vaginal trachelectomy.
    Plaikner A; Siegler K; Hertel H; Jacob A; Petzel A; Schubert M; Blohmer JU; Böhmer G; Marnitz S; Ragosch V; Domröse C; Oppelt P; Jülicher A; Schneider A; Willems A; Favero G; Köhler C
    Int J Gynecol Cancer; 2023 Oct; 33(10):1542-1547. PubMed ID: 37696645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Para-aortic lymph node involvement revisited in the light of the revised 2018 FIGO staging system for cervical cancer.
    Ayhan A; Aslan K; Öz M; Tohma YA; Kuşçu E; Meydanli MM
    Arch Gynecol Obstet; 2019 Sep; 300(3):675-682. PubMed ID: 31263988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the FIGO 2018 staging system of cervical cancer: Retrospective analysis of FIGO 2009 stage IB1 cervical cancer with tumor under 2 cm.
    Takahashi M; Sakai K; Iwasa N; Wada M; Hino M; Kurahashi T; Ueno M; Nakagawa H
    J Obstet Gynaecol Res; 2021 May; 47(5):1871-1877. PubMed ID: 33611822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
    Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
    Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of laparoscopic and open radical hysterectomy in cervical cancer patients with tumor size ≤2 cm.
    Chen X; Zhao N; Ye P; Chen J; Nan X; Zhao H; Zhou K; Zhang Y; Xue J; Zhou H; Shang H; Zhu H; Leanne VM; Yan X
    Int J Gynecol Cancer; 2020 May; 30(5):564-571. PubMed ID: 32276941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of neoadjuvant chemotherapy followed by radical surgery for FIGO stage IB2/IIA2 cervical cancer: A multi-center retrospective clinical study.
    Zhao H; He Y; Zhu LR; Wang JL; Guo HY; Xu T; Wang YQ; Yao Y; Wu YM
    Medicine (Baltimore); 2019 May; 98(21):e15604. PubMed ID: 31124937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between laparoscopic and abdominal radical hysterectomy for cervical adenosquamous carcinoma at stage IA2 to IIA2: A multicenter retrospective study.
    Teng X; Kang S; Li W; Ding H; Ling B; Zhu L; Wang D; Lang J; Liu P; Chen C
    J Obstet Gynaecol Res; 2023 Jun; 49(6):1592-1610. PubMed ID: 36919234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a prognostic nomogram for 2018 FIGO stages IB1, IB2, and IIA1 cervical cancer: a large multicenter study.
    Chen X; Duan H; Liu P; Lin L; Ni Y; Li D; Dai E; Zhan X; Li P; Huo Z; Bin X; Lang J; Chen C
    Ann Transl Med; 2022 Jan; 10(2):121. PubMed ID: 35282114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parametrial involvement in FIGO stage IB1 cervical carcinoma diagnostic impact of tumor diameter in preoperative magnetic resonance imaging.
    Kamimori T; Sakamoto K; Fujiwara K; Umayahara K; Sugiyama Y; Utsugi K; Takeshima N; Tanaka H; Gomi N; Takizawa K
    Int J Gynecol Cancer; 2011 Feb; 21(2):349-54. PubMed ID: 21721193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival associated with extent of radical hysterectomy in early-stage cervical cancer: a subanalysis of the Surveillance in Cervical CANcer (SCCAN) collaborative study.
    Bizzarri N; Querleu D; Dostálek L; van Lonkhuijzen LRCW; Giannarelli D; Lopez A; Salehi S; Ayhan A; Kim SH; Ortiz DI; Klat J; Landoni F; Pareja R; Manchanda R; Kosťun J; Ramirez PT; Meydanli MM; Odetto D; Laky R; Zapardiel I; Weinberger V; Dos Reis R; Pedone Anchora L; Amaro K; Akilli H; Abu-Rustum NR; Salcedo-Hernández RA; Javůrková V; Mom CH; Scambia G; Falconer H; Cibula D
    Am J Obstet Gynecol; 2023 Oct; 229(4):428.e1-428.e12. PubMed ID: 37336255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of pelvic MRI in routine clinical practice on staging of IB1-IIA2 cervical cancer.
    Zhang W; Chen C; Liu P; Li W; Hao M; Zhao W; Lu A; Ni Y
    Cancer Manag Res; 2019; 11():3603-3609. PubMed ID: 31118782
    [No Abstract]   [Full Text] [Related]  

  • 16. The upper limit of optimal tumor size in patients with FIGO 2018 stage IB2 cervical cancer undergoing radical hysterectomy.
    Hwang WY; Kim JH; Suh DH; Kim K; No JH; Kim YB
    Int J Gynecol Cancer; 2020 Jul; 30(7):975-980. PubMed ID: 32467336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperatively Assessable Clinical and Pathological Risk Factors for Parametrial Involvement in Surgically Treated FIGO Stage IB-IIA Cervical Cancer.
    Canaz E; Ozyurek ES; Erdem B; Aldikactioglu Talmac M; Yildiz Ozaydin I; Akbayir O; Numanoglu C; Ulker V
    Int J Gynecol Cancer; 2017 Oct; 27(8):1722-1728. PubMed ID: 28617687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can laparoscopic radical hysterectomy be a standard surgical modality in stage IA2-IIA cervical cancer?
    Hong JH; Choi JS; Lee JH; Eom JM; Ko JH; Bae JW; Park SH
    Gynecol Oncol; 2012 Oct; 127(1):102-6. PubMed ID: 22683586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-dense neoadjuvant chemotherapy before radical surgery in cervical cancer: a retrospective cohort study and systematic literature review.
    Caruso G; Bruni S; Lapresa M; De Vitis LA; Parma G; Minicucci V; Betella I; Schivardi G; Peccatori F; Lazzari R; Cliby W; Aletti GD; Zanagnolo V; Maggioni A; Colombo N; Multinu F
    Int J Gynecol Cancer; 2023 Nov; ():. PubMed ID: 37949488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-operative surgical algorithm: sentinel lymph node biopsy as predictor of parametrial involvement in early-stage cervical cancer.
    Balaya V; Bresset A; Guani B; Benoit L; Magaud L; Bonsang-Kitzis H; Ngo C; Mathevet P; Lécuru F;
    Int J Gynecol Cancer; 2020 Sep; 30(9):1317-1325. PubMed ID: 32753560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.